Pathophysiology of fibrinolysis.
作者信息
Declerck P J, Juhan-Vague I, Felez J, Wiman B
机构信息
Centre for Molecular and Vascular Biology, University Leuven, Belgium.
出版信息
J Intern Med. 1994 Oct;236(4):425-32. doi: 10.1111/j.1365-2796.1994.tb00820.x.
Abstract
摘要
相似文献
1
Pathophysiology of fibrinolysis.纤维蛋白溶解的病理生理学
J Intern Med. 1994 Oct;236(4):425-32. doi: 10.1111/j.1365-2796.1994.tb00820.x.
2
Fibrinolysis: molecular mechanism and pathophysiological aspects.纤维蛋白溶解：分子机制与病理生理学方面
Sangre (Barc). 1984;29(4-C):755-61.
3
Pathologic fibrinolysis as a cause of clinical bleeding.病理性纤维蛋白溶解作为临床出血的一个原因。
Semin Thromb Hemost. 1990 Jul;16(3):260-73. doi: 10.1055/s-2007-1002678.
4
The plasmin-antiplasmin system: structural and functional aspects.纤溶酶-抗纤溶酶系统：结构与功能方面。
Cell Mol Life Sci. 2011 Mar;68(5):785-801. doi: 10.1007/s00018-010-0566-5. Epub 2010 Dec 7.
5
Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.纤溶酶原激活剂和抑制剂与纤溶酶原及纤维蛋白的相互作用。
Semin Thromb Hemost. 1982 Jan;8(1):2-10. doi: 10.1055/s-2007-1005038.
6
Fibrinolysis inhibitors.纤维蛋白溶解抑制剂
Clin Lab Sci. 1997 Jul-Aug;10(4):212-8.
7
Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.α2-抗纤溶酶及其缺乏：纤溶失衡
Haemophilia. 2008 Nov;14(6):1250-4. doi: 10.1111/j.1365-2516.2008.01766.x.
8
[The regulation of fibrinolysis].[纤维蛋白溶解的调节]
Nihon Rinsho. 1989 Apr;47(4):739-45.
9
A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.纤溶酶原激活物与抗纤溶因子之间的平衡发生改变，导致肝硬化患者纤溶活性增强。
Gastroenterology. 1991 Nov;101(5):1382-90. doi: 10.1016/0016-5085(91)90092-y.
10
Natural inhibitors of fibrinolysis.纤维蛋白溶解的天然抑制剂。
J Clin Pathol Suppl (R Coll Pathol). 1980;14:24-30.
Zotero 插件